Cart
sales@molnova.com
Opiranserin
CAS No. 1441000-45-8
Opiranserin( VVZ-149 | VVZ-000149 )
Catalog No. M11871 CAS No. 1441000-45-8
Opiranserin (VVZ-149, VVZ-000149) is a potent, selective, mixed glycine GlyT2 transporter blocker (IC50= 0.86 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameOpiranserin
-
NoteResearch use only, not for human use.
-
Brief DescriptionOpiranserin (VVZ-149, VVZ-000149) is a potent, selective, mixed glycine GlyT2 transporter blocker (IC50= 0.86 uM).
-
DescriptionOpiranserin (VVZ-149, VVZ-000149) is a potent, selective, mixed glycine GlyT2 transporter blocker (IC50= 0.86 uM), purine P2X3 receptor antagonist (IC50=0.87 uM) and serotonin 5-HT2A receptor antagonist (IC50=1.3 uM); demonstrates analgesic efficacy for postoperative pain.Pain Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsVVZ-149 | VVZ-000149
-
PathwayMembrane Transporter/Ion Channel
-
TargetGlyT
-
RecptorGlyT
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number1441000-45-8
-
Formula Weight394.512
-
Molecular FormulaC21H34N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCC1(N(C)C)CCOCC1)C2=CC(OC)=C(OCCCC)C(OC)=C2
-
Chemical NameBenzamide, 4-butoxy-N-[[4-(dimethylamino)tetrahydro-2H-pyran-4-yl]methyl]-3,5-dimethoxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nedeljkovic SS, et al. BMJ Open. 2017 Feb 17;7(2):e011035.
2. Oh J, et al. J Clin Pharmacol. 2018 Jan;58(1):64-73.
molnova catalog
related products
-
PF-03463275
PF-03463275 (PF 3463275) ia an orally bioavailable, centrally penetrant, potent, reversible, selective, and competitive inhibitor of the human GlyT1 transporter with Ki of 13 nM.
-
Bitopertin R enantio...
A potent and selective GlyT1 inhibitor with EC50 of 54 nM.
-
AMG 747
A nanomolar potent, selective, and orally bioavailable glycine transporter type-1 (GlyT1) inhibitor for the treatment of negative symptoms associated with schizophrenia.
